BHVN vs HBAN · $1.66B cap vs P/E 13, rev $1.56B
Biohaven Ltd. (BHVN) versus Huntington Bancshares Incorporated (HBAN) — a side-by-side from cached financials, not a winner call.
Biohaven Ltd. (BHVN) is a biotechnology company listed on US.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
BHVN does not have a complete income-statement cache yet.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
BHVN currently screens at market cap $1.66B. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Not investment advice. Open the BHVN and HBAN stock pages for the full models.
Not investment advice.